| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.1181937 |
| P698 | PubMed publication ID | 19892968 |
| P50 | author | Luigi Naldini | Q16574299 |
| P2860 | cites work | Hot spots of retroviral integration in human CD34+ hematopoietic cells | Q28302694 |
| In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
| Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. | Q34508425 | ||
| Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy | Q35011497 | ||
| Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors | Q35064224 | ||
| Genome-wide analysis of retroviral DNA integration | Q36263002 | ||
| HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells | Q36326611 | ||
| Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. | Q36424249 | ||
| Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors | Q36713507 | ||
| The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy | Q37143395 | ||
| Gene therapy of inherited diseases | Q37191861 | ||
| Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-transduced CD34+ cells | Q37209028 | ||
| Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment | Q43487715 | ||
| Preliminary results of gene therapy for retinal degeneration. | Q43604527 | ||
| Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors | Q45855831 | ||
| Gene therapy for immunodeficiency due to adenosine deaminase deficiency. | Q45882856 | ||
| P433 | issue | 5954 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 805-806 | |
| P577 | publication date | 2009-11-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Medicine. A comeback for gene therapy | |
| P478 | volume | 326 |
| Q35483739 | A single epidermal stem cell strategy for safe ex vivo gene therapy. |
| Q36001666 | Abrogated cryptic activation of lentiviral transfer vectors |
| Q39512686 | Anti-angiogenesis by lentivirus-mediated small interfering RNA silencing of angiopoietin-2 gene in pancreatic carcinoma |
| Q26743393 | Clinical development of gene therapy: results and lessons from recent successes |
| Q35513622 | Combining stem cells and genes for effective therapeutics |
| Q34757199 | DARPins: an efficient targeting domain for lentiviral vectors |
| Q39682237 | Development of a lentiviral vector system to study the role of the Andes virus glycoproteins. |
| Q45875518 | Effects of lentivirus-mediated endostatin on endothelial progenitor cells |
| Q38654544 | Gene therapy research in Asia |
| Q34641722 | High-titre retroviral vector system for efficient gene delivery into human and mouse cells of haematopoietic and lymphocytic lineages |
| Q37784147 | Insights into neurogenesis and aging: potential therapy for degenerative disease? |
| Q34694796 | Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell |
| Q38655437 | NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment. |
| Q60932114 | Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye |
| Q39240392 | Radiosensitivity by ING4-IL-24 bicistronic adenovirus-mediated gene cotransfer on human breast cancer cells. |
| Q42863043 | Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors |
| Q33863533 | Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts |
| Q42212141 | The Business of RNAi Therapeutics in 2012 |
| Q36784566 | Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses. |
| Q44192537 | Updates and achievements in virology |
| Q45858720 | Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies |
Search more.